- Home
- INM vs MBIO Comparison
INM vs MBIO Comparison
Compare INM & MBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INM
- MBIO
- Stock Information
- Founded
- INM 1981
- MBIO 2015
- Country
- INM Canada
- MBIO United States
- Employees
- INM N/A
- MBIO N/A
- Industry
- INM Biotechnology: Pharmaceutical Preparations
- MBIO Biotechnology: Pharmaceutical Preparations
- Sector
- INM Health Care
- MBIO Health Care
- Exchange
- INM Nasdaq
- MBIO Nasdaq
- Market Cap
- INM 4.3M
- MBIO 4.7M
- IPO Year
- INM N/A
- MBIO N/A
- Fundamental
- Price
- INM $2.28
- MBIO $1.72
- Analyst Decision
- INM
- MBIO
- Analyst Count
- INM 0
- MBIO 0
- Target Price
- INM N/A
- MBIO N/A
- AVG Volume (30 Days)
- INM 93.9K
- MBIO 105.9K
- Earning Date
- INM 11-13-2025
- MBIO 11-07-2025
- Dividend Yield
- INM N/A
- MBIO N/A
- EPS Growth
- INM N/A
- MBIO N/A
- EPS
- INM N/A
- MBIO N/A
- Revenue
- INM $4,942,633.00
- MBIO N/A
- Revenue This Year
- INM N/A
- MBIO N/A
- Revenue Next Year
- INM N/A
- MBIO N/A
- P/E Ratio
- INM N/A
- MBIO N/A
- Revenue Growth
- INM 7.50
- MBIO N/A
- 52 Week Low
- INM $1.72
- MBIO $0.89
- 52 Week High
- INM $8.27
- MBIO $21.95
- Technical
- Relative Strength Index (RSI)
- INM 49.66
- MBIO 58.12
- Support Level
- INM $2.17
- MBIO $1.54
- Resistance Level
- INM $2.30
- MBIO $1.63
- Average True Range (ATR)
- INM 0.12
- MBIO 0.08
- MACD
- INM 0.01
- MBIO 0.01
- Stochastic Oscillator
- INM 41.16
- MBIO 75.50
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.
About MBIO Mustang Bio Inc.
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.